Sensulin

Pre-clinical

San Diego, United StatesFounded 2013sensulin.com

Sensulin is a preclinical biopharmaceutical company, that is developing a glucose-responsive insulin for type 1 and type 2 diabetes. Sensulin aims to substantially lower the risk of hypoglycemia, reduce the long-term complications associated with diabetes (eye & kidney disease, etc.), while

Founded

2013

Focus

Drug Delivery

About

Sensulin is a preclinical biopharmaceutical company, that is developing a glucose-responsive insulin for type 1 and type 2 diabetes. Sensulin aims to substantially lower the risk of hypoglycemia, reduce the long-term complications associated with diabetes (eye & kidney disease, etc.), while

Funding History

1

Total raised: $1.8M

Seed$1.8MUndisclosedMar 15, 2021

Company Info

TypePrivate

Founded2013

LocationSan Diego, United States

StagePre-clinical

Contact

Sectors

Drug Delivery & Formulation

SIMILAR COMPANIES

BASi Research Products

Pre-clinical · West Lafayette

Bay BioSciences

Pre-clinical · San Francisco

Pre-clinical · Cambridge

Pre-clinical · Memphis

Belcher Pharmaceuticals

Pre-clinical · Miami

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.